Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Highly physically active women at low risk of rheumatoid arthritis

11 Aug 2019

High physical activity levels reduce the risk of developing rheumatoid arthritis (RA) in women, a study has found.

The study involved 113,366 participants from the Nurses' Health Study II, among whom 506 developed RA (67.0 percent had seropositive RA) over 2,428,573 person‐years of follow‐up. Every participant completed biennial questionnaires to determine physical activity exposures and covariates.

Researchers evaluated the long‐term cumulative average number of hours spent in recreational physical activity 2–8 years prior to the RA diagnosis. This time span was chosen to reduce the potential for reverse causation bias, given that early RA affects physical activity prior to diagnosis.

Multivariable Cox regression analysis revealed that increasing cumulative average total hours of recreational physical activity had a protective association with the risk of RA. Relative to women engaging in <1 hour of physical activity per week, those who were more physically active had up to about a 30-percent lower risk of developing RA (2 to <4 hours/week: hazard ratio [HR], 0.92, 95 percent CI, 0.72–1.17; 4 to <7 hours/week: HR, 0.84, 0.63–1.12; ≥7 hours/week: HR, 0.67, 0.47–0.98; p-trend=0.02).

Body mass index mediated some of the effect of physical activity on all RA (14.0 percent; p=0.002) and on seropositive RA (20.0 percent; p=0.001), suggesting that both physical activity and weight-loss interventions could delay or even prevent the onset of seropositive RA, according to the researchers.

The present data contribute to the increasing evidence that metabolic factors play an important role in RA pathogenesis, they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.